India's Shilpa Medicare falls on US FDA's inspection report

Shilpa Medicare

31/10/2024 09:24

** Shares of Shilpa Medicare  SHME.NS  slide as much as 2.1%
to 827.15 rupees; last down 1.7%
    ** Pharma co's Bengaluru facility gets four observations in
Form 483 from the U.S. FDA
    ** Form 483 is a type of agency report of observations that
FDA inspectors deem objectionable
    ** Stock has more than doubled YTD, set for biggest annual
gain since 2014

 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))